Cargando…

Drug-eluting scaffold to deliver chemotherapeutic medication for management of pancreatic cancer after surgery

Traditional post-surgical chemotherapy for pancreatic cancer is notorious for its devastating side effects due to the high dosage required. On the other hand, legitimate concerns have been raised about nanoparticle-mediated drug delivery because of its potential cytotoxicity. Therefore, we explored...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Qian, Shen, Baiyong, Deng, Xiaxing, Chen, Hao, Jin, Jiabin, Zhang, Xing, Peng, Chenghong, Li, Hongwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716555/ https://www.ncbi.nlm.nih.gov/pubmed/23885173 http://dx.doi.org/10.2147/IJN.S47666

Ejemplares similares

Systematic Review and Meta-Analysis of Pancreatic Amylase Value on Postoperative Day 1 After Pancreatic Resection to Predict Postoperative Pancreatic Fistula
por: Lu, Xiongxiong, et al.
Publicado: (2016)

A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
por: Jin, Yangbing, et al.
Publicado: (2021)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
por: Shi, Yusheng, et al.
Publicado: (2021)

Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study
por: Weng, Yuanchi, et al.
Publicado: (2020)

Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis
por: Weng, Yuanchi, et al.
Publicado: (2020)

A Prospective Proteomic-Based Study for Identifying Potential Biomarkers for the Diagnosis of Cholangiocarcinoma
por: Shi, Yuan, et al.
Publicado: (2013)

Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma
por: Wen, Chenlei, et al.
Publicado: (2020)

The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas
por: Qian, Lihan, et al.
Publicado: (2020)

H2AK119Ub1 and H3K27Me3 in molecular staging for survival prediction of patients with pancreatic ductal adenocarcinoma
por: Chen, Shi, et al.
Publicado: (2014)

Oncogene APOL1 promotes proliferation and inhibits apoptosis via activating NOTCH1 signaling pathway in pancreatic cancer
por: Lin, Jiewei, et al.
Publicado: (2021)

NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells
por: Zhu, Yi, et al.
Publicado: (2015)

A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy
por: Wang, Yue, et al.
Publicado: (2019)

Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer
por: Li, Hongzhe, et al.
Publicado: (2017)

The Immunohistochemical Evaluation of Solid Pseudopapillary Tumors of the Pancreas and Pancreatic Neuroendocrine Tumors Reveals ERO1Lβ as a New Biomarker
por: Xie, Junjie, et al.
Publicado: (2016)

Robot-Assisted Middle Pancreatectomy for Elderly Patients: Our Initial Experience
por: Zhang, Tian, et al.
Publicado: (2015)

Minimally invasive distal pancreatectomy for PNETs: laparoscopic or robotic approach?
por: Zhang, Jiaqiang, et al.
Publicado: (2017)

The impact of Omicron pandemic and COVID‐19 vaccination on the pancreatic adenocarcinoma patients
por: Fu, Ningzhen, et al.
Publicado: (2022)

Association between miR34b/c Polymorphism rs4938723 and Cancer Risk: A Meta-Analysis of 11 Studies including 6169 Cases and 6337 Controls
por: Wang, Xinjing, et al.
Publicado: (2014)

mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer
por: Wang, Xinjing, et al.
Publicado: (2016)

Preliminary experience of the robot-assisted laparoscopic excision of a retroperitoneal mass: A case report
por: LIU, QIN, et al.
Publicado: (2014)

Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate‐adjusted analysis at the pre‐adjuvant chemotherapy timing
por: Fu, Ningzhen, et al.
Publicado: (2022)

Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer
por: Weng, Yuanchi, et al.
Publicado: (2023)

Shen’s Whole-Layer Tightly Appressed Anastomosis Technique for Duct-to-Mucosa Pancreaticojejunostomy in Pancreaticoduodenectomy
por: Zhang, Tian, et al.
Publicado: (2016)

Long-term outcomes of standard versus extended lymphadenectomy in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: A Chinese multi-center prospective randomized controlled trial
por: WANG, Weishen, et al.
Publicado: (2022)

miR-150-5p Inhibits Hepatoma Cell Migration and Invasion by Targeting MMP14
por: Li, Tao, et al.
Publicado: (2014)

Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs
por: Ma, Di, et al.
Publicado: (2022)

Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer
por: Qian, Hao, et al.
Publicado: (2021)

Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1
por: Zhai, Shuyu, et al.
Publicado: (2020)

miR-934 as a Prognostic Marker Facilitates Cell Proliferation and Migration of Pancreatic Tumor by Targeting PROX1
por: Jin, Yangbing, et al.
Publicado: (2020)

Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p/BPTF axis and degrading BIN1
por: Lin, Jiewei, et al.
Publicado: (2022)

The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility
por: Junjie, Xie, et al.
Publicado: (2012)

Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway
por: Lin, Jiewei, et al.
Publicado: (2021)

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study
por: Zou, Siyi, et al.
Publicado: (2022)

Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort
por: Zhan, Qian, et al.
Publicado: (2021)

Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases
por: Fu, Ningzhen, et al.
Publicado: (2021)

Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma
por: Wang, Xinjing, et al.
Publicado: (2018)

Real‐world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma
por: Wang, Chao, et al.
Publicado: (2022)

Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients
por: Fu, Ningzhen, et al.
Publicado: (2021)

TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy
por: Zhai, Shuyu, et al.
Publicado: (2019)

Modified protocol for enhanced recovery after surgery is beneficial for Chinese cancer patients undergoing pancreaticoduodenectomy
por: Deng, Xiaxing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mhgov08mnu1ulmto38bfi5e2e6